Search Results - "Necking, Oscar"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Minimal clinically important change in the MADRS anhedonia factor score: A pooled analysis of open-label studies with vortioxetine in patients with major depressive disorder by McIntyre, Roger S., Necking, Oscar, Schmidt, Simon Nitschky, Reines, Elin

    Published in Journal of affective disorders (15-10-2024)
    “…It is previously reported that the Montgomery–Åsberg Depression Rating Scale (MADRS) anhedonia factor score is correlated with scales assessing function in…”
    Get full text
    Journal Article
  2. 2

    Long-term safety and efficacy, including anhedonia, of vortioxetine for major depressive disorder: findings from two open-label studies by Mattingly, Gregory W., Necking, Oscar, Schmidt, Simon Nitschky, Reines, Elin, Ren, Hongye

    Published in Current medical research and opinion (03-04-2023)
    “…Evaluate the long-term safety and efficacy of vortioxetine in the management of major depressive disorder (MDD) in two open-label one-year studies, including a…”
    Get full text
    Journal Article
  3. 3

    Efficacy and safety of vortioxetine in treatment of patients with major depressive disorder and common co-morbid physical illness by Baldwin, David S., Necking, Oscar, Schmidt, Simon Nitschky, Ren, Hongye, Reines, Elin H.

    Published in Journal of affective disorders (15-08-2022)
    “…The multimodal antidepressant vortioxetine is effective in reducing somatic symptoms in patients with major depressive disorder (MDD), but little is known…”
    Get full text
    Journal Article
  4. 4

    Vortioxetine in children and adolescents with major depressive disorder: 6-month and 18-month open-label, flexible-dose, long-term extension studies by DelBello, Melissa P, Findling, Robert L, Huss, Michael, Necking, Oscar, Petersen, Maria L, Schmidt, Simon N, Rosen, Monika

    Published in European child & adolescent psychiatry (06-09-2024)
    “…Children and adolescents with severe or relapsing major depressive disorder (MDD) may require long-term antidepressant use, but safety and tolerability data on…”
    Get full text
    Journal Article